Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-MIP-1404 Imaging in High-Risk Prostate Cancer
NCT01667536Phase 2Completed
- Sponsor
- Molecular Insights Pharmaceuticals
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of trofolastat in prostate cancer (PCa), sponsored by Molecular Insights Pharmaceuticals. Started Aug 2012; status: completed.
02
Drugs
trofolastat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01667536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667536.